List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1745 studies with search of: "Carcinoma, Non-Small-Cell Lung"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Recurrent Non-Small Cell Lung Cancer
Intervention: Drug: FR901228
2 Recruiting Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma, Non-Small-Cell Lung: Stage IIIA (T3,N2 Only);   Carcinoma, Non-Small-Cell Lung: Stage IIIB;   Carcinoma, Non-Small-Cell Lung: Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator
3 Active, not recruiting Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Lung Cancer;   Stage IIIA Non Small Cell Lung Cancer;   Stage IIIB Non Small Cell Lung Cancer
Intervention: Drug: S-3304
4 Completed Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Non-Small Cell Lung;   Lung Neoplasms
Intervention: Drug: EKB-569
5 Active, not recruiting Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   NSCLC
Interventions: Drug: Erlotinib (tarceva);   Drug: Placebo
6 Active, not recruiting Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Non-Small Cell Lung
Interventions: Drug: SNDX-275;   Drug: erlotinib
7 Recruiting Phase I/II Open Label Trial of Continuous Once Daily Oral Treatment With BIBW 2992 - Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib.
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: BIBW 2992
8 Recruiting Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer;   Advanced Solid Tumor;   Metastatic Non-Small Cell Lung Cancer
Interventions: Drug: pazopanib + paclitaxel;   Drug: paclitaxel + carboplatin
9 Not yet recruiting A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: MM-121 + erlotinib
10 Recruiting Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer;   Metastatic Non-Small Cell Lung Cancer
Interventions: Drug: pazopanib and pemetrexed;   Drug: pemetrexed and cisplatin
11 Completed STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Conditions: Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: STA 4783
12 Active, not recruiting Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: MVA-MUC1-IL2
13 Terminated
Has Results 		A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Vorinostat;   Drug: erlotinib
14 Completed A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: LY900003
15 Terminated Clinical Trial to Test the Safety and Effectiveness of an Investigational Drug CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CHR-2797;   Drug: erlotinib
16 Completed ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: ALIMTA;   Drug: Carboplatin
17 Completed Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-Small Cell Lung Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: SGN-15;   Drug: Docetaxel
18 Recruiting Pharmacogenomic Study Realized on "Non-Small Cell Lung Carcinoma"
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
19 Enrolling by invitation Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gefitinib retreatment
20 Completed An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Intervention: Drug: Cetuximab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services